Related Experiment Video
Updated: Aug 17, 2026
07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
Cholesterol: from heart attacks to Alzheimer's disease
Robert L Raffai1, Karl H Weisgraber
1Department of Pathology, Gladstone Institutes of Cardiovascular Disease and Neurological Disease, University of California, San Francisco, CA 94141-9100, USA.
Journal of Lipid Research
|July 3, 2003
Summary
Alzheimer
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Amyloid-beta peptide (Abeta) accumulation and aggregation in the brain are key factors in Alzheimer's disease (AD).
- Understanding Abeta generation pathways is crucial for developing effective AD treatments.
Purpose of the Study:
- To explore cellular proteins and proteases involved in Abeta metabolism.
- To investigate the role of cholesterol in modulating cellular Abeta processing and its potential impact on AD.
Main Methods:
- Review of recent scientific literature on Abeta metabolism.
- Analysis of in vitro and in vivo studies examining cholesterol's influence on Abeta processing.
Main Results:
- Several cellular proteins and proteases identified that regulate Abeta generation.
- Evidence suggests cholesterol modulates cellular processing of Abeta, potentially influencing AD pathogenesis.
Conclusions:
- Blocking Abeta generation is a promising therapeutic strategy for Alzheimer's disease.
- Cholesterol's role in Abeta processing warrants further investigation for AD therapeutic development.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:18Lipids: Dietary Sources and Requirements
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...